Early localized prostate cancer is notoriously asymptomatic, meaning the body rarely displays overt physical hints or warning signs while fighting initial tumor development. However, as the disease progresses or causes localized benign enlargement and inflammation, subtle urinary changes can emerge, including a weak urine stream, increased nighttime frequency, difficulty initiating urination, or microscopic traces of blood in the urine or semen. Routine prostate-specific antigen blood testing remains the primary method for detecting early cellular changes long before physical symptoms manifest.